Evotec partners with Secarna to develop LNA drugsEvotec SE has secured a strategic partnership with Secarna Pharmaceuticals GmbH to co-develop a LNA drug pipeline. more ➔
Rapid test for pandemics Rapid tests have received a lot of attention during the Coronavirus pandemic, but as the number of tests available has increased, so has the confusion around the different types and what they can deliver. … more ➔
EC secures 300 million doses of COVID-19 vaccineThe European Commission has reserved 300 million doses from Sanofi SA’/GSK plc’s adjuvanted recombinant COVID-19 vaccine. more ➔
Antiviral drugs for pandemic preparedness Viral pandemics are not a once-in-a-lifetime event but a constant threat looming over our heads. While the fight against SARS-CoV-2 is currently a top priority, we should not lose sight of what might … more ➔
Roche’s IL-6 receptor blocker fails in Phase IIIRoche has reported the failure of its IL-6R antagonist tocilizumab in patients with COVID-19 putting the efficacy of IL-6 inhibition at question. more ➔
Enthera Pharmaceuticals Srl raises €28m in Series A financing Italian start-up Enthera Pharmaceuticals has raised €28m to advance restorative therapy for type 1 diabetes and inflammatory bowel disease. more ➔
Vital expertise in oncolytic virus productionOncolytic viruses, viral vectors for gene therapy and viral-vectored prophylactic vaccines, are new, innovative, and already successful approaches for the treatment of severe diseases. The production … more ➔
Polyphor AG bags CHF19.3 in equity financingSwiss Polyphor AG has strengthened its financial flexibility with an equity-linked financing. more ➔
A plucked chicken named Horizon Europe According to current information, the European Research Framework Programme "Horizon Europe" is likely to be among the indirect victims of the Corona pandemic: A large part of the funds earmarked … more ➔
Defining the bioprocess is early quality control As the process determines the product, product characteristics of biological drugs need to be analysed thoroughly right from the beginning of the drug development process. Early understanding of structure-function … more ➔
